Farimah Ashofteh

698 citations
11 papers · 427 indexed · h-index 7
Topics
Ocular Diseases and Behçet’s Syndrome (9 papers)Vasculitis and related conditions (5 papers)Retinal and Optic Conditions (4 papers)
Partner nations
Iran

In The Last Decade

Farimah Ashofteh

11 papers receiving 420 citations

Peers

Farimah Ashofteh
Comparison fields: 5 of 51
  • Ophthalmology 351
  • Pulmonary and Respiratory Medicine 197
  • Rheumatology 182
  • Molecular Biology 38
  • Epidemiology 32
Replace Erdal Başaran with:
Erdal Başaran Türkiye
Priyanka Doctor United States
MA Gürer Türkiye
Ida Orlando Italy
Lina Ma United States
Fulya Coşan Türkiye
Bunei Iizuka Japan
Sofia Tognon Italy
P. Fanlo Spain
L. Pérard France
Farimah Ashofteh relative to Erdal Başaran Türkiye Erdal Başaran's profile →
Citations per field
00.5×12×
Erdal Başaran · 1×
Citations per year

Countries citing papers authored by Farimah Ashofteh

Since Specialization
Citations

This map shows the geographic impact of Farimah Ashofteh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Farimah Ashofteh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Farimah Ashofteh more than expected).

Fields of papers citing papers by Farimah Ashofteh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Farimah Ashofteh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Farimah Ashofteh. The network helps show where Farimah Ashofteh may publish in the future.

Co-authorship network of co-authors of Farimah Ashofteh

This figure shows the co-authorship network connecting the top 25 collaborators of Farimah Ashofteh. A scholar is included among the top collaborators of Farimah Ashofteh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Farimah Ashofteh. Farimah Ashofteh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
#WorkIndexed citations
1 16
2 3
3 3
4 208
5 64
6 56
7 6
8 22
9 23
10 20
11 6

About Farimah Ashofteh

Farimah Ashofteh is a scholar working on Ophthalmology, Rheumatology and Hematology, having authored 11 papers that have together received 427 indexed citations. Recurring topics across this work include Ocular Diseases and Behçet’s Syndrome (9 papers), Vasculitis and related conditions (5 papers) and Retinal and Optic Conditions (4 papers). The work is most often cited by research in Ophthalmology (351 citations), Rheumatology (182 citations) and Pulmonary and Respiratory Medicine (197 citations). Farimah Ashofteh has collaborated with scholars based in Iran. Frequent co-authors include Massoomeh Akhlaghi, Fereydoun Davatchi, Farhad Shahram, Hormoz Shams, Abdolhadi Nadji, Cheyda Chams‐Davatchi, Bahar Sadeghi Abdollahi, Nooshin Mohtasham, Zahra Ghodsi and Tahereh Faezi. Their work appears in journals such as Clinical Rheumatology, Rheumatology International and Expert Review of Clinical Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026